Literature DB >> 30393378

Risk of developing type 2 diabetes according to blood pressure levels and presence or absence of hypertensive treatment: the Saku study.

Yukako Tatsumi1,2,3, Akiko Morimoto4, Kei Asayama5, Nao Sonoda6, Naomi Miyamatsu7, Yuko Ohno6, Yoshihiro Miyamoto8, Satoshi Izawa9, Takayoshi Ohkubo5.   

Abstract

The aim was to investigate the risk of developing type 2 diabetes according to blood pressure (BP) levels and presence or absence of hypertensive treatment. This 5-year cohort study comprised 3508 Japanese adults aged 30-74 years without diabetes who had undergone a medical checkup including a 75-g oral glucose tolerance test (OGTT) between April 2008 and March 2009 at Saku Central Hospital. Participants receiving antihypertensive treatment were categorized into controlled hypertension ( < 140/90 mmHg) or uncontrolled hypertension ( ≥ 140/90 mmHg) groups. Participants not receiving antihypertensive treatment were categorized: optimal BP ( < 120/80 mmHg), normal BP (120-129/80-84 mmHg), high-normal BP (130-139/85-89 mmHg), grade I hypertension (140-159/90-99 mmHg), and grade II/III hypertension ( ≥ 160/100 mmHg). Hazard ratios and 95% confidence intervals for the incidence of type 2 diabetes as defined by the 75-g OGTT were estimated using multivariable-adjusted Cox proportional hazard models in reference to optimal BP. During an average of 4.4 years of follow-up, 295 participants developed type 2 diabetes. Those with high-normal BP, grade I hypertension, grade II/III hypertension, and uncontrolled hypertension were at significantly higher risk for developing type 2 diabetes, with hazard ratios (95% confidence intervals) of 1.53 (1.03-2.29), 1.53 (1.02-2.32), 2.19 (1.01-4.77), and 1.81 (1.10-2.99), respectively. In conclusion, compared with those with optimal BP, individuals with BP ≥ 130/85 mmHg not receiving antihypertensive treatment and uncontrolled hypertensives with BP ≥ 140/90 mmHg receiving antihypertensive treatment were at a significantly higher risk for developing type 2 diabetes.

Entities:  

Keywords:  Cohort study; High blood pressure; Hypertension; Type 2 diabetes

Year:  2018        PMID: 30393378     DOI: 10.1038/s41440-018-0121-6

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  3 in total

1.  Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study.

Authors:  Shanhu Qiu; Xue Cai; Bo Xie; Yang Yuan; Zilin Sun; Tongzhi Wu
Journal:  Diabetes Metab J       Date:  2022-03-07       Impact factor: 5.893

2.  Exploration and Validation of the Performance of Hemoglobin A1c in Detecting Diabetes in Community-Dwellers With Hypertension.

Authors:  Shanhu Qiu; Ziwei Du; Wei Li; Juan Chen; Hang Wu; Jingbao Liu; Min Cai; Bei Wang; Haijian Guo; Zilin Sun
Journal:  Ann Lab Med       Date:  2020-06-17       Impact factor: 3.464

3.  Degree of Blood Pressure Control and Incident Diabetes Mellitus in Chinese Adults With Hypertension.

Authors:  Yuanyuan Zhang; Jing Nie; Yan Zhang; Jianping Li; Min Liang; Guobao Wang; Jianwei Tian; Chengzhang Liu; Binyan Wang; Yimin Cui; Xiaobin Wang; Yong Huo; Xiping Xu; Fan Fan Hou; Xianhui Qin
Journal:  J Am Heart Assoc       Date:  2020-08-05       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.